Most Plasmodium falciparum infections that are detected in community surveys are
characterized by low-density parasitaemia and the absence of clinical symptoms. Molecular …

The malaria vaccine Combination B comprises recombinant Plasmodium falciparum ring-infected
erythrocyte surface antigen and 2 merozoite surface proteins (MSP1 and MSP2) …

Background Planning and evaluating malaria control strategies relies on accurate definition
of parasite prevalence in the population. A large proportion of asymptomatic parasite …

Clonally variant expression of surface antigens allows the malaria parasite Plasmodium
falciparum to evade immune recognition during blood stage infection and secure malaria …

We recently developed a new PCR-restriction fragment length polymorphism (RFLP)-based
assay using the miniexon sequence from the genus Leishmania. Here we report the …

Carriage and density of gametocytes, the transmission stages of malaria parasites, are
determined for predicting the infectiousness of humans to mosquitoes. This measure is used for …

Background The undetectable hypnozoite reservoir for relapsing Plasmodium vivax and P.
ovale malarias presents a major challenge for malaria control and elimination in endemic …

Background The efficacy of anti-malarial drugs is assessed over a period of 28-63 days (depending
on the drugs' residence time) following initiation of treatment in order to capture late …

Individuals in areas of Plasmodium falciparum endemicity develop immunity to malaria after
repeated exposure. Knowledge of the acquisition and nature of protective immune …

We have designed a new genotyping scheme for molecular diagnosis of the different
Leishmania species pathogenic to humans. This scheme is based on PCR amplified sequences …